Lungevity Foundation is located in Chicago, IL. The organization was established in 2001. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 06/2022, Lungevity Foundation employed 46 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lungevity Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Lungevity Foundation generated $14.5m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 12.0% each year . All expenses for the organization totaled $13.7m during the year ending 06/2022. While expenses have increased by 11.3% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF LUNGEVITY FOUNDATION IS TO HAVE A MEANINGFUL AND IMMEDIATE IMPACT ON IMPROVING LUNG CANCER SURVIVAL RATES, ENSURE A HIGHER QUALITY OF LIFE FOR LUNG CANCER PATIENTS, AND PROVIDE A COMMUNITY FOR THOSE IMPACTED BY LUNG CANCER.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH SERVICES - FUNDING CLINICAL RESEARCH AWARDS IN LUNG CANCER TO BRING ADVANCES IN CLINICAL RESEARCH MORE RAPIDLY TO PATIENT CARE.
PATIENT AND PUBLIC EDUCATION - CREATES, UPDATES AND MAINTAINS A COLLECTION OF EDUCATIONAL TOOLS AND MATERIALS FOR PATIENTS, CAREGIVERS, AND HEALTHCARE PROFESSIONALS
IMPROVING ACCESS TO CARE - WORKS TO IMPROVE ACCESS TO LIFE-SAVING CARE IN UNDERSERVED COMMUNITIES THROUGH VARIOUS INITIATIVES, INCLUDING EFFORTS TO STREAMLINE THE CLINICAL TRIAL PROCESS AND MAKE IT MORE ACCESSIBLE TO PATIENTS, AND ENSURING BIOMARKER TESTING IS AVAILABLE TO ALL PATIENTS DIAGNOSED WITH NON-SMALL CELL LUNG CANCER.
SUPPORT SERVICES - OFFERS THE LARGEST ONLINE NETWORK OF SUPPORT AND IN-PERSON SURVIVORSHIP PROGRAMS FOR ALL PEOPLE AFFECTED BY LUNG CANCER, INCLUDING MESSAGE BOARDS, PEER-TO-PEER SUPPORT MATCHING SERVICE, AND NATIONAL SURVIVOR SUMMITS
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Andrea Stern Ferris President & CEO | OfficerTrustee | 40 | $244,371 |
Barbara Netter COO & CFO | Officer | 40 | $198,794 |
Upal Basu Roy Executive Director Of Research | 40 | $185,005 | |
Jeanne Regnante Chief Health Equity Officer | Officer | 40 | $182,482 |
Linda Wenger Chief Marketing Officer | Officer | 40 | $170,607 |
Rebecca Bull Chief Development Officer | Officer | 40 | $166,097 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $2,047,254 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $12,798,595 |
Noncash contributions included in lines 1a–1f | $121,202 |
Total Revenue from Contributions, Gifts, Grants & Similar | $14,845,849 |
Total Program Service Revenue | $0 |
Investment income | $2,932 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$4,642 |
Net Income from Fundraising Events | -$300,706 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $14,543,433 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $3,024,136 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $1,053,570 |
Compensation of current officers, directors, key employees. | $162,033 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $3,555,561 |
Pension plan accruals and contributions | $113,252 |
Other employee benefits | $514,870 |
Payroll taxes | $334,584 |
Fees for services: Management | $0 |
Fees for services: Legal | $14,560 |
Fees for services: Accounting | $29,950 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $775 |
Fees for services: Other | $2,198,016 |
Advertising and promotion | $1,454,654 |
Office expenses | $478,705 |
Information technology | $136,240 |
Royalties | $0 |
Occupancy | $277,935 |
Travel | $56,972 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $381,209 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $11,302 |
Insurance | $26,860 |
All other expenses | $0 |
Total functional expenses | $13,663,151 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,852,306 |
Savings and temporary cash investments | $7,489,920 |
Pledges and grants receivable | $791,579 |
Accounts receivable, net | $1,496,594 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $409,484 |
Net Land, buildings, and equipment | $26,037 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $16,133 |
Total assets | $12,082,053 |
Accounts payable and accrued expenses | $371,796 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $17,047 |
Total liabilities | $388,843 |
Net assets without donor restrictions | $4,800,497 |
Net assets with donor restrictions | $6,892,713 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $12,082,053 |
Over the last fiscal year, we have identified 1 grants that Lungevity Foundation has recieved totaling $12,500.
Awarding Organization | Amount |
---|---|
Joanne Andjohn Dallepezze Foundation Naples, FL PURPOSE: TO SUPPORT HEALTH CARE. | $12,500 |
Organization Name | Assets | Revenue |
---|---|---|
Lungevity Foundation Chicago, IL | $12,082,053 | $14,543,433 |
Pkd Foundation Kansas City, MO | $20,909,832 | $16,124,449 |
Citizens United For Research In Epilepsy Chicago, IL | $10,496,452 | $6,043,691 |
Omega Medical Grants Association Rosemont, IL | $5,080,670 | $4,530,118 |
American Medical Association Foundation Chicago, IL | $26,650,564 | $8,763,967 |
Leukemia Research Foundation Inc Northfield, IL | $5,035,074 | $2,910,174 |
Head For The Cure Kansas City, MO | $719,180 | $1,965,362 |
Levelup Kids Inc Kansas City, MO | $1,600,938 | $1,601,663 |
Partnership For Cures Chicago, IL | $2,901,397 | $2,128,264 |
Orthopaedic Foot & Ankle Foundation Rosemont, IL | $10,882,425 | $1,439,579 |
Bryon Riesch Paralysis Foundation Inc Waukesha, WI | $477,065 | $417,057 |
St Louis Life Sciences Project St Louis, MO | $288,211 | $470,000 |